PharMEDium recalls 45 lots of hydromorphone tainted with allergen

PharMEDium Services is recalling 45 lots of its injectable hydromorphone because they were classified as sulfite-free, but the products contain sulfites. 

"Serious adverse reactions could occur in patients with a sulfite allergy who are exposed to hydromorphone containing sulfites," the company said in its recall notice. 

The affected product is 0.5 mg/mL hydromorphone HCl in 0.9 percent sodium chloride 1 mL in 3 mL BD syringe. 

PharMEDium said it has notified its customers and arranged replacement orders. 

More articles on pharmacy:
Walmart cutting some pharmacy jobs
UPMC acquires community pharmacy in Pittsburgh
Oklahoma judge approves Teva's $85M opioid settlement

© Copyright ASC COMMUNICATIONS 2020. Interested in LINKING to or REPRINTING this content? View our policies by clicking here.

 

Featured Webinars

Featured Whitepapers